Cargando…

Allopurinol treatment adversely impacts left ventricular mass regression in patients with well-controlled hypertension

Previous studies have demonstrated that high-dose allopurinol is able to regress left ventricular (LV) mass in cohorts with established cardiovascular disease. The aim of this study was to assess whether treatment with high-dose allopurinol would regress LV mass in a cohort with essential hypertensi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gingles, Christopher R., Symon, Ruth, Gandy, Stephen J., Struthers, Allan D., Houston, Graeme, MacDonald, Thomas M., Lang, Chim C., Donnan, Peter T., George, Jacob
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	ORIGINAL PAPERS: Treatment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855336/ https://www.ncbi.nlm.nih.gov/pubmed/31268872 http://dx.doi.org/10.1097/HJH.0000000000002189

Ejemplares similares

An Increased B-Type Natriuretic Peptide in the Absence of a Cardiac Abnormality Identifies Those Whose Left Ventricular Mass Will Increase Over Time
por: Nadir, M. Adnan, et al.
Publicado: (2015)

A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial
por: Brown, Alexander J M, et al.
Publicado: (2020)

A Randomized, Controlled Trial of the Effect of Allopurinol on Left Ventricular Mass Index in Hemodialysis Patients
por: Rutherford, Elaine, et al.
Publicado: (2020)

Dapagliflozin Versus Placebo on Left Ventricular Remodeling in Patients With Diabetes and Heart Failure: The REFORM Trial
por: Singh, Jagdeep S.S., et al.
Publicado: (2020)

Effect of allopurinol on phosphocreatine recovery and muscle function in older people with impaired physical function: a randomised controlled trial
por: Witham, Miles D, et al.
Publicado: (2020)

Does dapagliflozin regress left ventricular hypertrophy in patients with type 2 diabetes? A prospective, double-blind, randomised, placebo-controlled study
por: Brown, Alexander J.M., et al.
Publicado: (2017)

A randomized, double-blind, placebo-controlled study to determine the effects of valsartan on exercise time in patients with symptomatic heart failure with preserved ejection fraction
por: Parthasarathy, Hari K., et al.
Publicado: (2009)

Allopurinol in Patients with Pulmonary Hypertension Associated with Chronic Lung Disease
por: Liu-Shiu-Cheong, Patrick S K, et al.
Publicado: (2020)

Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial
por: Noman, Awsan, et al.
Publicado: (2010)

Research into the effect Of SGLT2 inhibition on left ventricular remodelling in patients with heart failure and diabetes mellitus (REFORM) trial rationale and design
por: Singh, Jagdeep S. S., et al.
Publicado: (2016)

Transcatheter Aortic Valve Replacement and Surgical Aortic Valve Replacement Outcomes in Left Ventricular Assist Device Patients with Aortic Insufficiency
por: Rali, Aniket S, et al.
Publicado: (2022)

An Open‐Label Dose‐Finding Study of Allopurinol to Target Defined Reduction in Urate Levels in Hemodialysis Patients
por: Rutherford, Elaine, et al.
Publicado: (2017)

Impact of allopurinol use on urate concentration and cardiovascular outcome
por: Wei, Li, et al.
Publicado: (2011)

A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial
por: Mohan, Mohapradeep, et al.
Publicado: (2019)

Mechanical Circulatory Support for Right Ventricular Failure
por: DeFilippis, Ersilia M, et al.
Publicado: (2022)

Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress
por: George, Jacob, et al.
Publicado: (2009)

A Randomized Controlled Trial of Allopurinol in Patients With Peripheral Arterial Disease
por: Robertson, Alan J., et al.
Publicado: (2016)

Systemic arteriosclerosis is associated with left ventricular remodeling but not atherosclerosis: a TASCFORCE study
por: Weir-McCall, Jonathan R., et al.
Publicado: (2018)

Adverse events of special interest in clinical trials of rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and psoriasis with 37 066 patient-years of tofacitinib exposure
por: Burmester, Gerd R, et al.
Publicado: (2021)

Left Ventricular Noncompaction: Anatomical Phenotype or Distinct Cardiomyopathy?
por: Weir-McCall, Jonathan R., et al.
Publicado: (2016)

Treatment of Persistent Left Atrial Appendage Thrombus in Patients with Atrial Fibrillation on Adequate Oral Anticoagulation: Pathways of Care for All-comers and Heart Failure Patients
por: Katic, Josip, et al.
Publicado: (2023)

Severe adverse drug reaction to allopurinol
por: Lucas, Grace, et al.
Publicado: (2022)

Intervention against Excessive Alcohol Consumption in Primary Health Care: A Survey of GPs' Attitudes and Practices in England 10 Years On
por: Wilson, Graeme B., et al.
Publicado: (2011)

Safety and effect of high dose allopurinol in patients with severe left ventricular systolic dysfunction
por: Ansari-Ramandi, Mohammad Mostafa, et al.
Publicado: (2017)

Heart rate variability as an indicator of left ventricular systolic dysfunction
por: Shehab, Abdulla, et al.
Publicado: (2009)

3T MRI investigation of cardiac left ventricular structure and function in a UK population: The tayside screening for the prevention of cardiac events (TASCFORCE) study
por: Gandy, Stephen J., et al.
Publicado: (2016)

Cardiovascular Effects of Switching From Tobacco Cigarettes to Electronic Cigarettes
por: George, Jacob, et al.
Publicado: (2019)

Prediction of Adverse Post-Infarction Left Ventricular Remodeling Using a Multivariate Regression Model
por: Oleynikov, Valentin, et al.
Publicado: (2022)

Pulmonary arterial stiffening in COPD and its implications for right ventricular remodelling
por: Weir-McCall, Jonathan R., et al.
Publicado: (2018)

Allopurinol and global left myocardial function in heart failure patients
por: Nasr, Gamela, et al.
Publicado: (2010)

Development of a Psychologically Enhanced Interactive Online Intervention for Hazardous Drinking
por: Linke, Stuart, et al.
Publicado: (2008)

Twelve-Month Follow-up Results from a Randomized Controlled Trial of a Brief Personalized Feedback Intervention for Problem Drinkers
por: Cunningham, John A., et al.
Publicado: (2010)

Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial
por: Düngen, Hans-Dirk, et al.
Publicado: (2011)

Early Treatment for Women with Alcohol Addiction (EWA) Reduces Mortality: A Randomized Controlled Trial with Long-Term Register Follow-up
por: Gjestad, Rolf, et al.
Publicado: (2011)

Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial
por: Cohen-Solal, Alain, et al.
Publicado: (2009)

Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial
por: Siminiak, Tomasz, et al.
Publicado: (2012)

Awareness and Treatment of Alcohol Dependence in Japan: Results from Internet-Based Surveys in Persons, Family, Physicians and Society
por: Taguchi, Yurie, et al.
Publicado: (2014)

The Alcohol Improvement Programme: Evaluation of an Initiative to Address Alcohol-Related Health Harm in England
por: Thom, Betsy, et al.
Publicado: (2013)

Efficacy of As-Needed Nalmefene in Alcohol-Dependent Patients with at Least a High Drinking Risk Level: Results from a Subgroup Analysis of Two Randomized Controlled 6-Month Studies
por: van den Brink, Wim, et al.
Publicado: (2013)

Nine-year follow-up of local implantation of autologous skeletal myoblasts in a patient with coronary heart disease
por: Zhang, Dingguo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_et2o1ig75s36t2uldk65jutvi5